9018
The resulting exchanged products exhibited similar labeling patterns as [3H]1a. Diazirene-bear-
ing analog [3H]4a was labeled at the sites Ta:Tb:Tc in the ratio of 67.8:3.5:28.7 with a specific
activity of 82 Ci/mmol. The isotopic distribution for [3H]3a was more complex. Substantial
tritium buildup occurred at the benzophenone–carbonyl directed sites Td and Te, resulting in
the ratio of 28:3:13:30:26 for Ta:Tb:Tc:Td:Te. When the amount of iridium complex was
elevated further to 5 equiv., a noticeable increase of tritium content took place proportionally
at sites Tb and Tc,15 with a ratio of 26(Ta):4(Tb):18(Tc):27(Td):25(Te). The specific activity was
raised from 179 to 195 Ci/mmol.
In summary, organoiridium-mediated direct isotope exchange is a powerful methodology for
labeling compounds with complex structures regioselectively and to high specific activity, as
demonstrated in the one-step tritiations of paclitaxel and related photoaffinity analogs.
Acknowledgements
3
We thank S. H. Levinson, A. L. Freyer and F. G. Vogt for H NMR measurements, L. B.
Killmer for MS measurements, and C. R. Newsome for chiral HPLC assays on b-lactam
intermediates.
References
1. Bayley, H. Photogenerated Reagents in Biochemistry and Molecular Biology; Elsevier: Amsterdam, 1983.
2. Fleming, S. A. Tetrahedron 1995, 51, 12479–12520.
3. Shu, A. Y. L.; Saunders, D.; Levinson, S. H.; Landvatter, S. W.; Mahoney, A.; Senderoff, S. G.; Mack, J. F.;
Heys, J. R. J. Lab. Comp. Radiopharm. 1999, 42, 797–807.
4. Ojima, I.; Kuduk, S. D.; Chakravarty, S. Adv. Med. Chem. 1999, 4, 69–124.
5. Swindell, C. S.; Heerding, J. M.; Krauss, N. E.; Horwitz, S. B.; Rao, S. J. Med. Chem. 1994, 37, 1446–1449.
6. (a) Rimoldi, J. M.; Kingston, D. G. I.; Chaudhary, A. G.; Samaranayake, G.; Grover, S.; Hamel, E. J. Nat. Prod.
1993, 56, 1313–1330. (b) Dasgupta, D.; Park, H.; Harriman, G. C. B.; Georg, G. I.; Himes, R. H. J. Med. Chem.
1994, 37, 2976–2980. (c) Ojima, I.; Duclos, O.; Dorman, G.; Simonot, B.; Prestwich, G. D. J. Med. Chem. 1995,
38, 3891–3894. (d) Rao, S.; Orr, G. A.; Chaudhary, A. G.; Kingston, D. G. I.; Horwitz, D. B. J. Biol. Chem.
1995, 270, 20235–20238. (e) Wu, Q.; Bounaud, P.-Y.; Kuduk, S. D.; Yang, C.-P. H.; Ojima, I.; Horwitz, S. B.;
Orr, G. A. Biochemistry 1998, 37, 11272–11279. (f) Ojima, I.; Bounaud, P.-Y.; Ahern, D. G. Bioorg. Med. Chem.
Lett. 1999, 9, 1189–1194.
7. Heys, J. R.; Shu, A. Y. L.; Nice, L. E. In Synthesis and Applications of Isotopically Labelled Compounds; Allen,
J.; Voges, R., Eds.; Wiley: West Sussex, 1995; pp. 175–180.
8. This tritiated compound [3H]5 was made previously via a multistep sequence. Dorman, G.; Olszewski, J. D.;
Prestwich, G. D.; Hong, Y.; Ahern, D. G. J. Org. Chem. 1995, 60, 2292–2297.
9. General tritiation procedure: paclitaxel or derivatives (2 mg) and iridium complex (0.3 or 1.5 equiv.) in 1 mL of
CH2Cl2 were exposed to 3.5–4 Ci of carrier-free tritium gas in a stainless steel manifold. The mixtures were stirred
for 18 h (low catalyst loading) or 8 h (high catalyst loading). After removal of excess tritium gas, CH2Cl2, and
tritium labiles (by static vacuum distillation with repeated additions of MeOH), the crude products (91–334 mCi)
were purified by semi-preparative HPLC on octadecyl stationary phase eluted with water/MeCN/MeOH. The
resulting products (yields: 40–116 mCi) had radiochemical purities of 96–98% by HPLC-radiodetection. Specific
3
activities were determined by MS in chemical ionization (negative ion) mode using NH3 as the reagent gas. H
NMR were measured in CDCl3 to determine location of label. Assignments were made by independent 2D
experiments (Vogt, F. G. et al., manuscript in preparation) and in reference to Kingston, D. G. I.; Molinero, A.
A.; Rimoldi, J. M. In The Taxane Diterpenoids (Progress in the Chemistry of Natural Products); Herz, W.; Kirby,
G. W.; Moore, R. E.; Steglich, W.; Tamm, C., Eds.; Springer-Verlag: Wien, New York, 1993; Vol. 61, pp. 37–39.